CluePoints Announces Free Risk-Based Monitoring Strategy Review
We’re thrilled to announce that CluePoints is now offering a complimentary Risk-Based Monitoring strategy Check-up and Risk Management review, aimed at helping sponsors and CROs accelerate their path to successful Risk-Based Monitoring adoption. Steve Young, Senior Vice President of US Operations for CluePoints, will leverage his twenty plus years of industry experience to help companies identify how […]
CluePoints Appoints Steve Young As Senior Vice President Of US Operations
Cambridge, MA – CluePoints, a leading provider of Risk-Based Monitoring (RBM) and Data Quality Oversight solutions for clinical trials, has appointed Steve Young as Senior Vice President of its US Operations. The appointment marks a key strategic move for the company in optimizing its operational performance, customer support and service delivery across North America. Young […]
CluePoints CEO, François Torche, Honored In PharmaVOICE 100
Cambridge, MA – CluePoints, a leading provider of Risk-Based Monitoring (RBM) solutions for clinical trials, has today announced that its CEO, François Torche, has been selected by PharmaVOICE as one of the top 100 most influential people in the life-sciences industry. François was recognized for his pivotal role in developing and promoting Central Statistical Monitoring (CSM), a […]
CluePoints Risk-Based Monitoring Platform (Version 1.9.0) Is Live!
We’re thrilled to announce that CluePoints’ latest version (1.9.0) of the Central Monitoring platform is live! Version 1.9.0 adds an abundance of new features (as requested by customers) and extensions to existing functionality. There’s lots to cover, so let’s get started. Trends Analysis The addition of the trends analysis functionality provides the study team with a workbench […]
CluePoints Founder, Marc Buyse To Deliver Clinical Trial Data Quality Course At The ASA Biopharmaceutical Workshop
The ASA Biopharmaceutical Section Regulatory-Industry Statistics Workshop is fast approaching and we’re thrilled to announce that CluePoints Founder, Marc Buyse will deliver a course with Paul Schuette, FDA; Richard C Zink, JMP Life Sciences, focused on methods to assess data integrity in clinical trials. Course: SC3 Short Course 3: An Overview of Methods to Assess Data Integrity in Clinical […]
Unveiling CluePoints’ New And Improved Risk-Based Monitoring Software
Today, we’re thrilled to unveil CluePoints’ latest release of its award-winning Risk-Based Monitoring Software. For this release, we wanted to hone in on several customer feature requests to deliver a solution that further advances the ability to meet the guidance proposed by regulators regarding Risk-Based Monitoring. In addition to an abundance of new features, we’ve […]
CluePoints Announce 2nd Annual Risk-Based Monitoring Roadshows To Take Place In Basel, Switzerland & Cambridge, UK
Join CluePoints CEO Francois Torche and OmniComm Sr. Director Steve Young at this special thought leadership event where you will hear about the benefits derived from an integrated solution for electronic data capture (EDC) technology, targeted source data verification (SDV), and centralized analytics/key risk indicators (KRIs). Expect to learn about; Best practices for RBM study planning and execution, […]
CluePoints Named Clinical Research & Excellence Awards Finalist
Awards recognize CluePoints’ Risk-Based Monitoring solution in the ‘Best Sponsor-Focused Technological Development’ category. Cambridge, MA – CluePoints, a leading software provider of Risk-Based Monitoring (RBM) solutions for clinical trials, has been named a finalist in the ‘Best Sponsor-Focused Technological Development’ category for the 2016 Clinical Research & Excellence (CARE) Awards. The company’s SaaS Central Statistical […]
CluePoints And Widler & Schiemann Collaborate On Complete Risk-Management Solution For Clinical Trials In Line With New Industry Guidance
Partnership will combine CluePoints’ Risk-Based Monitoring Software with Widler & Schiemann’s Consultancy Services Cambridge, MA – CluePoints, a leading software provider of risk-based monitoring (RBM) solutions for clinical trials, today announced a strategic collaboration with clinical trials business solutions consultancy, Widler & Schiemann Ltd. The collaboration will bring together CluePoints’ award-winning RBM software with Widler […]
CluePoints Partners with OmniComm Systems® to Offer Collective Risk-Based Monitoring & Electronic Data Capture Solution
Cambridge, MA – CluePoints, a leading software provider of risk-based monitoring (RBM) solutions for clinical trials, today announced a partnership with leading eClinical solutions provider, OmniComm Systems (OmniComm). Under the partnership, the two companies will work together to deliver OmniComm’s electronic data capture (EDC) technology and services integrated with CluePoints’ RBM software, offering customers a […]